FDA Inspection 1035804 — Panacea Biotec Pharma Limited

Panacea Biotec Pharma Limited — FEI 3007187282

The FDA completed an inspection of Panacea Biotec Pharma Limited on December 13, 2017 in Solan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 13, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Solan (India)